Arcadia Biosciences, Inc. (RKDA)

Market Cap	4.60M
Revenue (ttm)	9.96M
Net Income (ttm)	-15.38M
Shares Out	616.07K
EPS (ttm)	-25.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,208
Open	7.28
Previous Close	7.87
Day's Range	7.23 - 7.75
52-Week Range	6.69 - 68.40
Beta	0.11
Analysts	Buy
Price Target	102.00 (+1,265.46%)
Earnings Date	May 11, 2023

About RKDA

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.

• Industry: Agricultural Inputs
• Sector: Materials
• IPO Date: May 15, 2015
• Employees: 58
• Stock Exchange: NASDAQ
• Ticker Symbol: RKDA

Financial Performance

In 2022, RKDA's revenue was $9.96 million, an increase of 46.84% compared to the previous year's $6.78 million. Losses were -$15.38 million, 4.88% more than in 2021.

Analyst Forecast

According to 8 analysts, the average rating for RKDA stock is "Buy." The 12-month stock price forecast is $102.0, which is an increase of 1,265.46% from the latest price.

Price Target

$102.0

(1,265.46% upside)

Analyst Consensus: Buy